Transmission line with heat transfer ability

Information

  • Patent Grant
  • 11944376
  • Patent Number
    11,944,376
  • Date Filed
    Monday, July 29, 2019
    4 years ago
  • Date Issued
    Tuesday, April 2, 2024
    a month ago
Abstract
The present invention relates to systems and devices for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In particular, the present invention relates to systems and devices for the delivery of energy with heat transfer ability. In some embodiments, the systems and devices also have variable characteristic impedance as a result of the use of heat transfer materials. In certain embodiments, methods are provided for treating a tissue region (e.g., a tumor) through application of energy with the systems and devices of the present invention.
Description
FIELD OF THE INVENTION

The present invention relates to systems and devices for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In particular, the present invention relates to systems and devices for the delivery of energy with heat transfer ability. In some embodiments, the systems and devices also have variable characteristic impedance as a result of the use of heat transfer materials. In certain embodiments, methods are provided for treating a tissue region (e.g., a tumor) through application of energy with the systems and devices of the present invention.


BACKGROUND

Ablation is an important therapeutic strategy for treating certain tissues such as benign and malignant tumors, cardiac arrhythmias, cardiac dysrhythmias and tachycardia. Most approved ablation systems utilize radio frequency (RF) energy as the ablating energy source. Accordingly, a variety of RF based catheters and power supplies are currently available to physicians. However, RF energy has several limitations, including the rapid dissipation of energy in surface tissues resulting in shallow “burns” and failure to access deeper tumor or arrhythmic tissues. Another limitation of RF ablation systems is the tendency of eschar and clot formation to form on the energy emitting electrodes which limits the further deposition of electrical energy.


Microwave energy is an effective energy source for heating biological tissues and is used in such applications as, for example, cancer treatment and preheating of blood prior to infusions. Accordingly, in view of the drawbacks of the traditional ablation techniques, there has recently been a great deal of interest in using microwave energy as an ablation energy source. The advantage of microwave energy over RF is the deeper penetration into tissue, insensitivity to charring, lack of necessity for grounding, more reliable energy deposition, faster tissue heating, and the capability to produce much larger thermal lesions than RF, which greatly simplifies the actual ablation procedures. Accordingly, there are a number of devices under development that utilize electromagnetic energy in the microwave frequency range as the ablation energy source (see, e.g., U.S. Pat. Nos. 4,641,649, 5,246,438, 5,405,346, 5,314,466, 5,800,494, 5,957,969, 6,471,696, 6,878,147, and 6,962,586; each of which is herein incorporated by reference in their entireties).


Unfortunately, current devices configured to deliver microwave energy have drawbacks. For example, current devices produce relatively small lesions because of practical limits in power and treatment time. Current devices have power limitations in that the power carrying capacity of the feedlines is small. Larger diameter feedlines are undesirable, however, because they are less easily inserted percutaneously and may increase procedural complication rates. In addition, heating of the feedline at high powers can lead to burns around the area of insertion for the device.


Improved systems and devices for delivering energy to a tissue region are needed. In addition, improved systems and devices capable of delivering microwave energy without corresponding microwave energy loss are needed. In addition, systems and devices capable of percutaneous delivery of microwave energy to a subject's tissue without undesired tissue burning are needed. Furthermore, systems for delivery of desired amounts of microwave energy without requiring physically large invasive components are needed.


SUMMARY OF THE INVENTION

The present invention relates to systems and devices for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, intraluminal ablation of a hollow viscus, cardiac ablation for treatment of arrhythmias, electrosurgery, tissue harvest, cosmetic surgery, intraocular use, etc.). In particular, the present invention relates to systems and devices for the delivery of energy with heat transfer ability. In some embodiments, the systems and devices also have variable characteristic impedance as a result of the use of heat transfer materials. In certain embodiments, methods are provided for treating a tissue region (e.g., a tumor) through application of energy with the systems and devices of the present invention.


The present invention provides a variety of heat transfer mechanisms. In some embodiments, heat transfer is provided in small diameter devices. For example, in some embodiments, the outer diameter of the device is equivalent to, or smaller than, a 16-gauge needle (e.g., equal or smaller than a 17-gauge needles, a 20-gauge needle, etc.). Embodiments of the present invention provide configurations of the devices that balance energy delivery, heat management, and size. Existing devices, to provide appropriate energy delivery and heat management, are large in diameter, making them undesirable or unsuitable for many applications. In some embodiments, the present invention provides small diameter devices with optimized energy and heating characteristics by providing a cooling material within a coaxial or triaxial cable. For example, in some embodiments, the cooling material is provided within an inner conductor, within a dielectric material separating an inner and outer conductor of a coaxial cable (or central conductor of a triaxial cable), between an inner conductor and dielectric material, between dielectric material and outer conductor of a coaxial cable (or central conductor of a triaxial cable), between the outer two conductors of a triaxial cable, or outside of the outmost conductor of a coaxial or triaxial cable. Examples of some such embodiments are described in more detail below. In some embodiments, space is created for the cooling material, while maintaining the small diameter, by one or more of: a) removing all of or a portion of a dielectric material; b) removing a portion of an inner, central, or outer conductor; c) using thin conductive coatings as conductors; and d) using deformable tubing to carry cooling material within a coaxial or triaxial cable. In some embodiments, the coolant material is directly flowed through a created space. In other embodiments one or more tubes is provided in the space and coolant is flowed in the tube(s) and/or in the tube(s) and the space outside of the tube(s). In some embodiments, cooling material is provided in one direction (e.g., down the device or up the device) through a tube and the opposition direction outside of a tube. The tubes may be rigid or deformable. For example, in some embodiments, an inner conductor is contained within a minimal amount of dielectric material, the dielectric material is coated with a thin conductive film or is covered in a conductive foil so as to provide a coaxial structure, one or more deformable tubes are assembled outside of the film or foil, and a conductive outer member, having a small outer diameter, is placed of the assembly to provide a triaxial device having a small diameter combined with suitable energy delivery and heat management capabilities. By providing sufficient cooling, in a small diameter device, high amounts of power can be sent through the device without overheating, permitting, for example, tissue ablation that would otherwise only be achievable with larger diameter devices. In some embodiments, the tube for conducting coolant is replaced by a fiber whose wicking action enables the flow of coolant in a space-efficient manner.


In some embodiments, the cooling material is provided along only a portion of an energy delivery device. For example, in some embodiments, an energy delivery device comprises a distal tip, an antenna connected to the tip and configured to deliver energy, a feed line that connects to the antenna on the proximal end of the antenna, and a handle at the proximal end of the feed line. In some embodiments, only the handle is contacted with the cooling material. In some embodiments, only the feed line, or portion thereof (e.g., 90% of the length thereof or less, 80%, 70%, 60%, 50%, 40%, etc.), is contacted with the cooling material. In some embodiments, both the handle and the feed line, or a portion thereof, is contacted with the cooling material. In some embodiments, the antenna and/or tip are not contacted with the cooling material (e.g., the cooling material is only flowed to the feed line, and does not travel a sufficient length of the device to reach the antenna).


In some embodiments, the systems, devices, and methods of the present invention provide coaxial transmission lines that allow cooling by circulation of a coolant material through the coaxial transmission line (e.g., circulation of a coolant material through coolant tubes positioned within the coaxial cable) (e.g., through flowing of a coolant material through the dielectric of the coaxial component). In some embodiments, the devices are configured to minimize the diameter of the device, while permitting the passage of the coolant. This is accomplished, in some embodiments, by positioning of deformable coolant tubes (e.g., Kapton tubes) within the coaxial cable. In such embodiments, a triaxial cable comprises a dielectric material positioned between an inner conductor and a middle coaxial shield, and deformable coolant tubes positioned between the middle coaxial shield and an outer conductor. The devices are not limited to a particular middle coaxial shield. In some embodiments, the middle coaxial shield is a thin (e.g., 0.25 mm, 0.5 mm, 1.0 mm, 1.2 mm, 1.4 mm, 1.6 mm, 2.5 mm, etc.) flexible metal (e.g., copper). The devices are not limited to particular coolant tubes. In some embodiments, the coolant tubes are deformable such that upon positioning within a coaxial tube, the tubes will deform but retain an ability to circulate a coolant material (e.g., nitrogen, carbon dioxide, water). In some embodiments, the coolant tubes are Kapton tubes or similar polymer films. As such, the devices providing coolant tubes provide not only an ability to control the temperature of the device (e.g., through circulation of coolant material through the coolant tubes), but also provide an ability to retain its small size (e.g., due to the use of deformable coolant tubes that do not increase the overall diameter of the device).


In some embodiments, the devices are configured to minimize the diameter of the device, while permitting the passage of the coolant, by replacing strips of a solid dielectric material with channels through which a coolant is transferred. In some embodiments, the channels are generated by stripping the dielectric material along the length of the coaxial cable from one or more (e.g., two, three, four) zones. With the removed portions of the dielectric material creating channels for transfer of the coolant, the stripped component fits within a smaller outer conductor than it did prior to removal of the dielectric material (see FIG. 1C, element 300). This provides for smaller devices with all of the advantages derived therefrom. In some embodiments where multiple channels are employed, coolant transfer may be in alternative directions through one or more of the channels. An advantage of the devices is that the diameter of the coaxial cable does not need to be increased to accommodate coolant. This permits the use of cooled devices that are minimally invasive and permits access to regions of a body that are otherwise inaccessible or accessible only with undesired risk. The use of coolant also permits greater energy delivery and/or energy deliver for prolonged periods of time.


The systems, devices, and methods of the present invention further allow for adjustment of the characteristic impedance of the coaxial transmission line. In particular, the dielectric properties of the coolant (or of a non-coolant material that is passed through the coolant tubes and/or channel(s)) may be adjusted to alter the bulk complex permittivity of the dielectric medium separating the outer and inner conductors. In some embodiments, changes in the characteristic impedance are made during a procedure to, for example, optimize energy delivery, tissue effects, temperature, or other desired properties of the system, device, or application. In other embodiments, a flow material is selected prior to a procedure based on the desired parameters and maintained throughout the entire procedure. Thus, the present invention provides systems, devices, and methods that allow an antenna radiating in a changing dielectric environment to be adjusted to resonate in the changing environment to, for example, allow adaptive tuning of the antenna to ensure peak efficiency of operation. As desired, the fluid flow also allows heat transfer to and from the coaxial cable. The present invention is not limited by the means by which the characteristic impedance is altered. In some embodiments, the coolant tubes and/or channels or hollowed out areas contain a vacuum or partial vacuum. In some embodiments, impedance is varied by filling the vacuum with a material (e.g., any material that provides the desired result). Adjustments may be made at one or more time points or continuously.


The present invention is not limited by the method by which material is flowed through the dielectric. In some embodiments, channels are used. In some embodiments, the channel is in contact with both the inner and outer conductors (i.e., entirely removes solid dielectric material from the region so that the flowed material contacts both the inner and outer conductors when flowed through the channel). In some embodiments, the channel is cut through only a portion of the dielectric material so that the flowed material is in contact with either the inner or outer conductor and the remaining dielectric material. In some embodiments, the channels are linear along the length of the coaxial cable. In some embodiments, the channels are non-linear. In some embodiments, where more than one channel is used, the channels run parallel to one another. In other embodiments, the channels are not parallel. In some embodiments, the channels cross one another. In some embodiments, the channels remove over 50% (e.g., 60%, 70%, 80%, etc.) of the solid dielectric material. In some embodiments, the channels remove substantially all of the solid dielectric material.


The present invention is not limited by the nature of the material that is flowed through the dielectric material. In some embodiments, the material is selected to maximize the ability to control the characteristic impedance of the device, to maximize heat transfer to or from the coaxial cable, or to optimize a combination of control of the characteristic impedance and heat transfer. In some embodiments, the material that is flowed through the dielectric material is a liquid. In some embodiments, the material is a gas. In some embodiments, the material is a combination of liquid or gas. In some embodiments, the liquid and/or gas is provided at the respective critical point temperature. The present invention is not limited to the use of liquids or gasses. In some embodiments, the material is a slurry, a gel, or the like. In some embodiments, a coolant fluid is used. Any coolant fluid now known or later developed may be used. Exemplary coolant fluids include, but are not limited to, one or more of or combinations of, water, glycol, air, inert gasses, carbon dioxide, nitrogen, helium, sulfur hexafluoride, organic chemical solutions (e.g., ethylene glycol, diethylene glycol, or propylene glycol), oils (e.g., mineral oils, silicone oils, fluorocarbon oils), liquid metals, freons, halomethanes, liquified propane, other haloalkanes, anhydrous ammonia, sulfur dioxide.


In some embodiments, the systems, methods, and devices of the present invention are configured to permit control over the parameters of fluid infusion through the device. In some embodiments, the device is manually adjusted by the user (e.g., a treating physician or technician) as desired. In some embodiments, the adjustments are automated. In some embodiments, the devices are configured with or used with sensors that provide information to the user or the automated systems (e.g., comprising processors and/or software configured for receiving the information and adjusting fluid infusion or other device parameters accordingly). Parameters that may be regulated include, but are not limited to, speed of infusion of the fluid, concentration of ions or other components that affect the properties of the fluid (e.g., dielectric properties, heat transfer properties, flow rate, etc.), temperature of the fluid, type of fluid, mixture ratios (e.g., mixtures of gas/fluid for precise tuning or cooling). Thus, the present invention provides systems, devices, and methods employing a feed-back loop that can change one or more desired parameters to tune the device (e.g., antenna) more accurately, or speed up the infusion of the fluid if the device, portions of the device, or tissue of the subject reaches an undesired temperature (or a temperature for an undesired period of time).


The present invention is not limited by the type of device or the uses employed. Indeed, the devices may be configured in any desired manner. Likewise, the systems and devices may be used in any application where energy is to be delivered. Such uses include any and all medical, veterinary, and research applications. However, the systems and devices of the present invention may be used in agricultural settings, manufacturing settings, mechanical settings, or any other application where energy is to be delivered.


The device is not limited to delivering a particular type of energy. In some embodiments, the type of energy delivered by the device is microwave energy, in other embodiments the type of energy is radio frequency energy while in other embodiments it is multiple types of energy. In some embodiments, the device is combined with other medical devices such as cutting devices. The cutting devices may also employ energy, such as laser or radiofrequency energy.


In some embodiments, the device is configured for percutaneous, laparoscopic, intravascular, intracardiac, or surgical delivery of energy. In some embodiments, the device is configured for delivery of energy to a target tissue or region. The present invention is not limited by the nature of the target tissue or region. Uses include, but are not limited to, treatment of heart arrhythmia, tumor ablation (benign and malignant), control of bleeding during surgery, after trauma, for any other control of bleeding, removal of soft tissue, tissue resection and harvest, treatment of varicose veins, intraluminal tissue ablation (e.g., to treat esophageal pathologies such as Barrett's Esophagus and esophageal adenocarcinoma), treatment of bony tumors, normal bone, and benign bony conditions, intraocular uses, uses in cosmetic surgery, treatment of pathologies of the central nervous system including brain tumors and electrical disturbances, and cauterization of blood vessels or tissue for any purposes. In some embodiments, the surgical application comprises ablation therapy (e.g., to achieve coagulation necrosis). In some embodiments, the surgical application comprises tumor ablation to target, for example, metastatic tumors. In some embodiments, the device is configured for movement and positioning, with minimal damage to the tissue or organism, at any desired location, including but not limited to, the brain, neck, chest, abdomen, and pelvis. In some embodiments, the device is configured for guided delivery, for example, by computerized tomography, ultrasound, magnetic resonance imaging, fluoroscopy, and the like.


The device is not limited to a particular type of coaxial transmission line. In some embodiments, the coaxial transmission line has an inner conductor, a dielectric element, and an outer shield (e.g., outer conductor). In some embodiments, transmission line has a triaxial configuration and has therein a middle coaxial shield (which can be, for example, a metallic foil, film, mesh, or spiral conductor) positioned between the dielectric element and the outer conductor. In some embodiments, the outer shield is a 20-gauge needle or a component of similar diameter to a 20-gauge needle. Preferably, the outer shield is not larger than a 16-gauge needle (e.g., no larger than an 18-gauge needle). In some embodiments, the outer shield is a 17-gauge needle. However, in some embodiments, larger devices are used, as desired. For example, in some embodiments, a 12-gauge diameter is used. The present invention is not limited by the size of the outer shield component. In some embodiments, the center conductor is configured to extend beyond the outer shield for purposes of delivering energy to a desired location. In preferred embodiments, some or all of the feedline characteristic impedance is optimized for minimum power dissipation, irrespective of the type of antenna that terminates at its distal end.


In some embodiments, the systems of the present invention provide multiple feedlines and/or multiple antennas to affect one or more locations in a subject. Such application include, but are not limited to, treating large tumor masses or tumor masses having irregular shapes, where one or more of the components capable of delivered energy is inserted to a first position of a tumor and one or more of the components is inserted to a second (third, etc.) position of a tumor. In some embodiments, a first component capable of delivering energy is a first size and a second component capable of delivery energy is a second size. Such an embodiment, adds to the choices a user has in delivering the desired amount of energy for a particular application. For example, in embodiments where the size of the injury created by insertion of the device into a subject is less relevant and the tissue zone to be ablated is larger, the user may select a larger needle to deliver more energy. In contrast, where the injury associated with the insertion is to be minimized, two or more smaller needles may be used (e.g., bundled together or separately). In preferred embodiments, some or all of the feedline characteristic impedance is optimized for minimum power dissipation, irrespective of the type of antenna that terminates its distal end. In some embodiments, the device has therein multiple antenna arrays of the same or different shapes (e.g., umbrella-shaped probes, trident shaped, etc.).


In some embodiments, one or more components of the systems of the present invention may contain a coating (e.g., Teflon or any other insulator) to help reduce heating or to impart other desired properties to the component or system. For example, in some embodiments of the present invention, the antennae, and or the feedline, are coated with a biocompatible material that reduces tissue sticking to the device (e.g., Teflon). Coating prevents undesired tissue sticking during use of the device, and thereby permits the antennae to be used without additional cooling measures (e.g., the antennae may be used without having coolant directly engaging the antennae).


In some embodiments, the device further comprises a tuning element for adjusting the amount of energy delivered to the tissue region. In some embodiments, the tuning element is manually adjusted by a user of the system. In some embodiments, the device is pretuned to the desired tissue and is fixed throughout the procedure. In some embodiments, the tuning element is automatically adjusted and controlled by a processor of the present invention. In some embodiments, the processor adjusts the energy delivery over time to provide constant energy throughout a procedure, taking into account any number of desired factors including, but not limited to, heat, nature and/or location of target tissue, size of lesion desired, length of treatment time, proximity to sensitive organ areas, and the like. In some embodiments, the system comprises a sensor that provides feedback to the user or to a processor that monitors the function of the device continuously or at time points. The sensor may record and/or report back any number of properties, including, but not limited to, heat at one or more positions of a components of the system, heat at the tissue, property of the tissue, and the like. The sensor may be in the form of an imaging device such as CT, ultrasound, magnetic resonance imaging, or any other imaging device. In some embodiments, particularly for research application, the system records and stores the information for use in future optimization of the system generally and/or for optimization of energy delivery under particular conditions (e.g., patient type, tissue type, size and shape of target region, location of target region, etc.).


In certain embodiments, the present invention provides systems for ablation therapy, comprising a power distributor and a device of the present invention for percutaneous delivery of energy to a tissue region. In some embodiments, the power distributor includes a power splitter configured to deliver energy to multiple antennas (e.g., the same energy power to each antenna, different energy powers to different antennas). In some embodiments, the power splitter is able to receive power from one or more power distributors.


In certain embodiments, the present invention provides methods for treating a tissue region, comprising providing a target tissue or organism and a device of the present invention for delivery of energy to a tissue region. In such embodiments, the method further comprises the positioning of the device in the vicinity of the tissue region, and the percutaneous delivering of an amount of energy with the device to the tissue region. In some embodiments, the delivering of the energy results in, for example, the ablation of the tissue region and/or thrombosis of a blood vessel, and/or electroporation of a tissue region. In some embodiments, the tissue region is a tumor. In some embodiments, the tissue region comprises one or more of the heart, liver, genitalia, stomach, lung, large intestine, small intestine, brain, neck, bone, kidney, muscle, tendon, blood vessel, prostate, bladder, and spinal cord.


The systems, devices, and methods of the present invention may be used in conjunction with other systems, device, and methods. For example, the systems, devices, and methods of the present invention may be used with other ablation devices, other medical devices, diagnostic methods and reagents, imaging methods and reagents, and therapeutic methods and agents. Use may be concurrent or may occur before or after another intervention. The present invention contemplates the use systems, devices, and methods of the present invention in conjunction with any other medical interventions.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1A-C shows a transverse cross-section schematic of a standard coaxial cable (100) and two embodiments of the present invention (200, 300).



FIG. 2 shows an embodiment of the present invention where longitudinal fluid channels run the length of the cable to the feed point of the antenna, wherein a small transverse channel is inserted to allow fluid flow back through a different channel.



FIG. 3 shows an embodiment of a device of the present invention to flow fluid to and from the cable.



FIG. 4 shows a graph of characteristic impedance of a simulated line versus relative permittivity of the fluid layer.



FIG. 5 shows a graph of characteristic impedance versus conductivity of the fluid layer.



FIG. 6A-B shows graphs of reflection coefficient versus frequency for a triaxial antenna with standard coaxial cable (FIG. 6A) and the same antenna fed by a water-filled cable (FIG. 6B).



FIG. 7A-F show a series of cross-sectional views of cables having an inner conductor, a dielectric material, a middle coaxial shield, and an outer conductor, in some embodiments of the present invention.





DETAILED DESCRIPTION

The present invention relates to systems and devices for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, treatment of arrhythmias, cautery, vascular thrombosis, electrosurgery, tissue harvest, etc.). In particular, the present invention relates to systems and devices for the delivery of energy with heat transfer ability. In some embodiments, the systems and devices also have variable characteristic impedance as a result of the use of heat transfer materials. In certain embodiments, methods are provided for treating a tissue region (e.g., a tumor) through application of energy with the systems and devices of the present invention.


In preferred embodiments, the systems, devices, and methods of the present invention employ microwave energy. The use of microwave energy in the ablation of tissue has numerous advantages. For example, microwaves have a broad field of power density (e.g., approximately 2 cm surrounding an antenna depending on the wavelength of the applied energy) with a correspondingly large zone of active heating, thereby allowing uniform tissue ablation both within a targeted zone and in perivascular regions (see, e.g., International Publication No. WO 2006/004585; herein incorporated by reference in its entirety). In addition, microwave energy has the ability to ablate large or multiple zones of tissue using multiple probes with more rapid tissue heating. Microwave energy has an ability to penetrate tissue to create deep lesions with less surface heating. Energy delivery times are shorter than with radiofrequency energy and probes can heat tissue sufficiently to create an even and symmetrical lesion of predictable and controllable depth. Microwave energy is generally safe when used near vessels. Also, microwaves do not rely on electrical conduction; they can radiate through tissue, fluid/blood, as well as air. Therefore, they can be used in tissue, lumens, lungs, and intravascularly.


The illustrated embodiments provided below describe the systems and devices of the present invention in terms of medical applications (e.g., ablation of tissue through delivery of microwave energy). However, it should be appreciated that the systems and devices of the present invention are not limited to a medical applications. In addition, the illustrated embodiments describe the systems and devices of the present invention in terms of medical devices configured for tissue ablation. It should be appreciated that the systems and devices of the present invention are not limited to medical devices configured for tissue ablation. The illustrated embodiments describe the systems and devices of the present invention in terms of microwave energy. It should be appreciated that the systems and devices of the present invention are not limited to a particular type of energy (e.g., radiofrequency energy).


The systems and devices of the present invention provide numerous advantages over the currently available systems and devices. For example, a major drawback with currently available medical devices that utilize microwave energy is the undesired dissipation of the energy through transmission lines onto a subject's tissue resulting in undesired burning. Such microwave energy loss results from limitations within the design of currently available medical devices. In particular, medical devices utilizing microwave energy transmit energy through coaxial cables having therein a dielectric material (e.g., polyfluorothetraethylene or PTFE) surrounding an inner conductor. Dielectric materials such as PTFE have a finite conductivity, which result in the undesired heating of transmission lines. This is particularly true when one supplies the necessary amounts of energy for a sufficient period of time to enable tissue ablation. The present invention provides systems, devices, and methods that overcome this limitation. In particular, the present invention provides means for flowing coolant through the device to manage heating. As described in more detail below, the overall temperature of the transmission lines within the medical devices of the present invention are reduced, and therefore, reduces undesired tissue heating. Thus, in some embodiments, the systems and devices of the present invention are provided with a coolant that runs through at least a portion of the dielectric material, which may be partly or completely made of mesh or other porous construction. This is in contrast, for example, to coolant systems that are provided in an external cooling jacket that surrounds a coaxial cable, antenna, or device.


In addition, in some embodiments, by providing improved coaxial transmission lines configured for coolant material circulation, by using one or more space-saving techniques, the coaxial transmission line may be designed such that it can fit within very small needles (e.g., 16-20 gauge needles or smaller). Typically, medical devices configured to delivery microwave energy are designed to fit within large needles due to bulky dielectric materials. Microwave ablation has not been extensively applied clinically due to the large probe size (14 gauge) and relatively small zone of necrosis (1.6 cm in diameter) (Seki T et al., Cancer 74:817 (1994)) that is created by the only commercial device (Microtaze, Nippon Shoji, Osaka, Japan. 2.450 MHz, 1.6 mm diameter probe, 70 W for 60 seconds). Other devices use a cooling external water jacket that also increases probe size and can increase tissue damage. These large probe sizes increase the risk of complications when used in the chest and abdomen. In some embodiments of the present invention, the maximum outer diameter of the portion of the device that enters a subject is 16-18 gauge or less (20 gauge or less).


Moreover, by providing improved coaxial transmission lines designed to prevent undesired heating, the coaxial cables may be heated to temperatures at or above (e.g., 10%, 20%, 50%, etc. above) the manufacturer's rated temperature failure points.


The energy delivery systems of the present invention contemplate the use of any type of device configured to deliver (e.g., emit) energy (e.g., ablation device, surgical device, etc.) (see, e.g., U.S. Pat. Nos. 7,101,369, 7,033,352, 6,893,436, 6,878,147, 6,823,218, 6,817,999, 6,635,055, 6,471,696, 6,383,182, 6,312,427, 6,287,302, 6,277,113, 6,251,128, 6,245,062, 6,026,331, 6,016,811, 5,810,803, 5,800,494, 5,788,692, 5,405,346, 4,494,539, U.S. patent application Ser. Nos. 11/514,628, 11/502,783, 11/452,637, 11/440,331, 11,237,430, 11/237,136, 11/236,985, 10/980,699, 10/961,994, 10/961,761, 10/834,802, 10/370,179, 09/847,181; U.S. Provisional Patent Nos. 60/785,690, 60/785,467, and 60/785,466; Great Britain Patent Application Nos. 2,406,521, 2,388,039; European Patent No. 1395190; and International Patent Application Nos. WO 06/008481, WO 06/002943, WO 05/034783, WO 04/112628, WO 04/033039, WO 04/026122, WO 03/088858, WO 03/039385 WO 95/04385; each herein incorporated by reference in their entireties). Such devices include any and all medical, veterinary, and research applications devices configured for energy emission, as well as devices used in agricultural settings, manufacturing settings, mechanical settings, or any other application where energy is to be delivered.


In some embodiments, the systems utilize energy delivery devices having therein antennae configured to emit energy (e.g., microwave energy, radiofrequency energy). The systems are not limited to particular types or designs of antennae (e.g., ablation device, surgical device, etc.). In some embodiments, the systems utilize energy delivery devices having linearly shaped antennae (see, e.g., U.S. Pat. Nos. 6,878,147, 4,494,539, U.S. patent application Ser. Nos. 10/961,994, 10/961,761; U.S. Provisional Patent Nos. 60/785,690, 60/785,467, and 60/785,466; and International Patent Application No., WO 03/039385; each herein incorporated by reference in their entireties). In some embodiments, the systems utilize energy delivery devices having non-linearly shaped antennae (see, e.g., U.S. Pat. Nos. 6,251,128, 6,016,811, and 5,800,494, U.S. patent application Ser. No. 09/847,181, and International Patent Application No. WO 03/088858; each herein incorporated by reference in their entireties). In some embodiments, the antennae have horn reflection components (see, e.g., U.S. Pat. Nos. 6,527,768, 6,287,302; each herein incorporated by reference in their entireties). In some embodiments, the antenna has a directional reflection shield (see, e.g., U.S. Pat. No. 6,312,427; herein incorporated by reference in its entirety). In some embodiments, the antenna has therein a securing component so as to secure the energy delivery device within a particular tissue region (see, e.g., U.S. Pat. Nos. 6,364,876, and 5,741,249; each herein incorporated by reference in their entireties).


The energy emitting devices of embodiments of the present invention may be manufactured in a variety of ways. An exemplary manufacturing method for a triaxial device of some embodiments of the invention is provided below. In some embodiments, an interior portion comprising the inner conductor is made first. In some such embodiments, a inner conductor is provide and is coated with a dielectric material and a thin metal coating. In some embodiments, no dielectric material is used (e.g., air or other material occupies the space between the inner conductor and the thin metal coating). In some embodiments, the thin metal coating is a metal foil that is wrapped around the inner conductor and/or dielectric material. In some embodiments, the dielectric material and metal coating are provided by use of a metal-coated deformable tube (e.g., Kapton tube) that is inserted over the inner conductor. One or more of the components may be glued to one another. In some embodiments, this assembly is manufactured in long lengths that are cut to size. In other embodiments, the assembly is manufactured at final length. In some embodiments, coolant tubes (e.g., deformable tubes) are then attached to the outer surface of the conductive metal or film. The coolant tubes may run any desired length along the device. This assembly may also be manufactured in long lengths and cut to size. An outer conductor is then placed over the assembly, encompassing the inner conductor, the metal film or foil, and the coolant tubes. In some embodiments, the inner conductor extends distally beyond the length of the other components. This portion of the inner conductor may be covered in a non-conductive material, so as to provide an antenna for energy delivery. In some embodiments, a non-conducive tip is positioned on the distal end of the device. The tip may be fashioned with a sharp point to assist in penetration of and navigation through tissue. In some embodiments, a handle is positioned on the proximal end of the device. In some embodiments, the handle is provided as two or more pieces that snap or are fused together. The handle pieces contain channels to accommodate an electric connection between the triaxial cable a power delivery system and between a coolant source and coolant tubes or channels in the energy delivery device. In some embodiments, connections are sealed. In some embodiments, one or more of the tip, antenna portion, feed line portion (comprising the triaxial cable), and handle are coated with a material that provides one or more of: biocompatibility and non-stick surface. Non-conductive segments may be attached to metal coated segments via any desired mechanism. In some embodiments, connections are designed to “snap fit” into a secure engagement, for example, at the end of the triaxial cable. In some embodiments, glue or other adhesives are used. In some embodiments, insert molding/thermoforming is used. For example, holes may be drilled in the end of the outer conductor of the triaxial cable and insert molding/thermoforming is carried out by melting the non-conductive material so that it forms into the holes.


The present invention is not limited to a particular coaxial transmission line cross-sectional shape. Indeed, in some embodiments, the shape of the coaxial transmission line and/or the dielectric element is selected and/or adjustable to fit a particular need. For example, potential cross-sectional shapes for the transmission lines or portions thereof (e.g., at the circumference of the dielectric material, the middle coaxial shield, the outer conductor, etc.). include, but are not limited to, circular, oval, square, rectangular, oblong, diagonal, triangular, or various irregular shapes. In some embodiments, the shapes are designed so as to accommodate and/or include flow channels within the transmission line. In some embodiments, the transmission line is shaped to assume a particular region of interest (e.g., a body orifice). Certain preferred embodiments of the present invention are described below. The present invention is not limited to these embodiments.



FIG. 1A-C shows a conventional coaxial cable 100 and two exemplary cables of the present invention, 200 and 300. A coaxial cable is made, generally, of three separate spaces: a metallic inner conductor 110, a metallic outer conductor 130, and a space between them. The space between them is usually filled with a low-loss dielectric material 120 (e.g., polyfluorotetraethylene, or PTFE) to mechanically support the inner conductor and maintain it with the outer conductor. The characteristic impedance of a coaxial cable is fixed by the ratio of diameters of the inner conductor and dielectric material (i.e., inner diameter of the outer conductor) and the permittivity of the space between them. Usually, the permittivity is fixed because of the solid polymer comprising it. However, in embodiments of the present invention, a fluid with variable permittivity (or conductivity) at least partially occupies this space, permitting the characteristic impedance of the cable to be adjusted.


In one embodiment of the present invention, the coaxial cable 200 has the outer portion of the dielectric material removed to create a channel between the dielectric material 120 and the outer conductor 130. In the embodiments shown, the created space is separated into four distinct channels 150 by the addition of support lines 140 configured to maintain the space between the outer conductor 130 and the solid dielectric material 120. The support lines 140 may be made of any desired material and may be the same or a different material as the solid dielectric material 120. The presence of multiple channels permits one or more of the channels to permit flow in one direction (towards the proximal end of the cable) and one or more other channels to permit flow in the opposite direction (towards the distal end of the cable).


In another embodiment, the coaxial cable 300 has a substantial portion of the solid dielectric material 120 removed. Such an embodiment may be generated, for example, by stripping away the solid dielectric material 120 down to the surface of inner conductor 110 on each of four sides. In another embodiment, strips of dielectric material 120 are applied to an inner conductor 110 to create the structure. In this embodiment, four channels 150 are created. By removing a substantial amount of the dielectric material 120, the diameter of the outer conductor 130 is substantially reduced. The corners provided by the remaining dielectric material 120 provide the support to maintain the position of the outer conductor 130 with respect to the inner conductor 110. In this embodiment, the overall diameter of the coaxial cable 300 and the device is substantially reduced.


Large electric fields caused by large powers and small cable diameters can generate heat within the dielectric material that lead to unwanted heating of the medium (e.g., tissue) into which the cable is immersed. Thus, it is desirable to be able to counteract this effect and sink heat out of the cable to reduce any unwanted heating. The present invention provides devices configured to circulate coolant materials for purposes of sinking heat away from the cable itself, and thereby reducing unwanted heating of the medium (e.g., tissue).


The present invention is not limited by the nature of the coolant material employed. Coolants included, but are not limited to, liquids and gasses. Exemplary coolant fluids include, but are not limited to, one or more of or combinations of, water, glycol, air, inert gasses, carbon dioxide, nitrogen, helium, sulfur hexafluoride, ionic solutions (e.g., sodium chloride with or without potassium and other ions), dextrose in water, Ringer's lactate, organic chemical solutions (e.g., ethylene glycol, diethylene glycol, or propylene glycol), oils (e.g., mineral oils, silicone oils, fluorocarbon oils), liquid metals, freons, halomethanes, liquified propane, other haloalkanes, anhydrous ammonia, sulfur dioxide. In some embodiments, cooling occurs, at least in part, by changing concentrations of coolant, pressure, or volume. For example, cooling can be achieved via gas coolants using the Joule-Thompson effect. In some embodiments, the cooling is provided by a chemical reaction. The devices are not limited to a particular type of temperature reducing chemical reaction. In some embodiments, the temperature reducing chemical reaction is an endothermic reaction. The devices are not limited to a particular manner of applying endothermic reactions for purposes of preventing undesired heating. In some embodiments, first and second chemicals are flowed into the device such that they react to reduce the temperature of the device. In some embodiments, the device is prepared with the first and second chemicals preloaded in the device. In some embodiments, the chemicals are separated by a barrier that is removed when desired. In some embodiments, the barrier is configured to melt upon exposure to a predetermined temperature or temperature range. In such embodiments, the device initiates the endothermic reaction only upon reaching a heat level that merits cooling. In some embodiments, multiple different barriers are located throughout the device such that local cooling occurs only at those portions of the device where undesired heating is occurring. In some embodiment, the barriers used are beads that encompass one of the two chemicals. In some embodiments, the barriers are walls (e.g., discs in the shape of washers) that melt to combine the two chemicals. In some embodiments, the barriers are made of wax that is configured to melt at a predetermined temperature. The devices are not limited to a particular type, kind or amount of meltable material. In some embodiments, the meltable material is biocompatible. The devices are not limited to a particular type, kind, or amount of first and second chemicals, so long as their mixture results in a temperature reducing chemical reaction. In some embodiments, the first material includes barium hydroxide octahydrate crystals and the second material is dry ammonium chloride. In some embodiments, the first material is water and the second material is ammonium chloride. In some embodiments, the first material is thionyl chloride (SOCl2) and the second material is cobalt(II) sulfate heptahydrate. In some embodiments, the first material is water and the second material is ammonium nitrate. In some embodiments, the first material is water and the second material is potassium chloride. In some embodiments, the first material is ethanoic acid and the second material is sodium carbonate. In some embodiments, a meltable material is used that, itself, reduces heat by melting an flowing in a manner such that the heat at the outer surface of the device is reduced. FIGS. 2, 3, and 7 show device embodiments configured to provide this benefit.



FIG. 2 shows a coaxial cable 400 comprising an outer conductor 401, and an inner conductor 402 that may be extended from the end of the device to deliver energy to a target tissue. The solid dielectric material 403 has a channel carved therein 404 that permits fluid flow down the longitudinal length of the coaxial cable 400 to the feed point of the antenna. In this embodiment, a small transverse channel 405 is provided to allow fluid flow back through a different channel (not shown). In some embodiments, a fluid reservoir is provided instead of the small transverse channel. A fluid reservoir can be created, for example, by removing the dielectric material of the coaxial cable at the location where the cooling channel terminates.



FIG. 3 shows a cut-away view of a coaxial cable 500 with an inner conductor 502 covered by a coating 503 contained within a solid dielectric material 501. Two channels 504 are cut through the interior of the dielectric material 501 to permit flow of fluid. A small transverse channel 505 is provided to allow fluid flow between the two channels.



FIGS. 7A-F show a series of cross-sectional views of cables 750 having an inner conductor 760, a dielectric material 765, a middle coaxial shield 770 (shown as a thin film or foil in 7D and E), and an outer conductor 775. FIGS. 7A-E show the coaxial cable 750 having therein gap areas 780 inbetween the middle coaxial shield 770 and the outer conductor 775. FIG. 7F shows the coaxial cable 750 having therein gap areas 780 within the outer conductor 775. In some embodiments, the gap areas 780 may be used for circulating a coolant material. In some embodiments, such a coaxial cable may have only one gap area, while in other embodiments, as shown in FIGS. 7B and 7F, there are two segregated gap areas. Such a configuration as shown in FIGS. 7B and/or 7F permit the input of coolant material through one of the gap areas and the output of the inputted coolant material through the other gap area. Such a configuration as shown in FIG. 7B permits the input of coolant material through one of the gap areas and the output of the inputted coolant material through the other gap area. In some embodiments, channels are created by deforming an otherwise circular assembly comprising an inner conductor, dielectric material and middle coaxial shield. In some embodiments, the channels are created by filling the space between with the coaxial shield and the outer conductor with a material and removing a portion of the material to create a channel. In some embodiments, the material is a curable material and strips of the material are cured by providing heat along the length of the exterior surface of the outer conductor to create thin, cured strips. The uncured material is then removed, to create channels that are separated by the barriers of cured material.


In some embodiments, as shown in FIGS. 7A, C, D and E the coaxial cable 750 has therein at least one coolant tube 785 positioned within the gap areas 780. The present invention is not limited to a particular type or kind of coolant tube 785. In some embodiments, the composition of the coolant tube 785 is metal, plastic, ceramic, Kevlar, etc. In some embodiments, the coolant tube 785 is a deformable tube capable of assuming a variety of shapes and configurations (e.g., a Kapton Tube). In some embodiment, the coolant tube 785 is temperature resistant.


In some embodiments, as shown in FIGS. 7A, D and E, the coolant tube(s) 785 is positioned such that it does not effect the thickness of the middle coaxial shield 770 or the outer conductor 775. In some embodiments, as shown in FIGS. 7C, the coolant tube(s) 785 is positioned such that it encroaches upon the middle coaxial shield 770 thereby reducing the thickness of the middle coaxial shield 770 at the location of encroachment. In some embodiments, the coolant tube(s) is positioned such that it encroaches upon the middle coaxial shield 770 and the outer conductor 775 thereby reducing the thickness of the middle coaxial shield 770 and the outer conductor 775 at the location of encroachment. In some embodiments, the coolant tube(s) is positioned such that it encroaches upon only the outer conductor 775 thereby reducing the thickness of the outer conductor 775 at the location of encroachment.


In some embodiments, as shown in FIGS. 7A and 7C, only one coolant tube 785 is positioned within the gap area 780. In such embodiments, a coolant material may be inputted through the coolant tube 785 and outputted through the gap area 780, or the coolant material inputted through the gap area 780 and outputted through the coolant tube 785.


In some embodiments, as shown in FIG. 7D, two coolant tubes 785 are positioned within the gap area 780. In such embodiments, the coolant material may be inputted through the two coolant tubes 785 and outputted through the gap area 780, or the coolant material inputted through one of the coolant tubes 785 and outputted through the second coolant tube 785, or the coolant material inputted through the gap area 780, and outputted through the coolant tubes 785.


In some embodiments, as shown in FIG. 7E, a plurality of coolant tubes 785 are positioned along the outside of the middle coaxial shield 770. In such embodiments, any number (e.g., 1, 2, 5, 10) of the coolant tubes 785 may be used to input the coolant material and any number (e.g., 1, 2, 5, 10) of the coolant tubes 785 may be used to output the coolant material. In some embodiments, half of the coolant tubes 785 are used to input coolant material and half of the coolant tubes 785 are used to output coolant material. In some embodiments, the gap area 780 may be used to input or output coolant material. In some embodiments, the coolant tubes 785 are conductive and replace the outer conductor. In some embodiments, a thin non-conductive sheath 790 encases the device.


In some embodiments, the coaxial cable prevents unwanted heating along the length of the coaxial cable through the positioning of a plurality of coolant tubes along the exterior of the outer conductor. FIG. 7F provides one such example. In this configuration channels are provided in the out conductor. However, in other embodiments, channels (e.g., tubing) may affixed to the outer surface of the outer conductor. In some such embodiments, the device may be covered in a sheath (e.g., shrink-wrap material) to securely hold the channels to the outside of the outer conductor. These embodiments, may cause the device to take on oval or modified oval shape.


In some embodiments, the device has a handle attached with the device, wherein the handle is configured to, for example, control the passing of coolant into and out of the coolant channels and/or coolant tubes. In some embodiments, the handle is also connected to coolant and energy delivery systems via a one or more cables. In some embodiments, a single cable connects the energy delivery system (e.g., generator) and coolant system to the handle. In some embodiments, the cable is attached to the handle at a 90-degree angle or approximately a 90-degree angle.


In some embodiments, the coolant handling system is provided to manage the flow of coolant to the device. In some embodiments, the coolant handling system is manually controlled. In some embodiments, the coolant handling system is automatically controlled. In some embodiments, the temperature of returning coolant is monitored and the temperature is used to determine flow rate of input coolant. In some embodiments, the energy delivery is also control based on temperature of one or more portions of the device. An automated or partially automated system may control a wide variety of operations. For example, in some embodiments, when the device is ready for operation, the automated system primes the cooling system by circulating coolant or another material through the coolant passageways. Once the system is primed, the program enters a normal coolant management protocol. In some embodiments, one or more temperature sensors that monitor temperature of the coolant, one or more portions of the device, or the surrounding tissue, are used to control coolant flow and/or energy delivery. For example, in some embodiments, the temperature of the tip or antenna is monitored to make sure it is sufficiently high (e.g., before starting a procedure or before activating the energy delivery mode), while the temperature of the feed line or handle is monitored to maintain a portion of the device at sufficiently low temperature to avoid tissue damage proximal to the treated region.


The impedance of the device connected to the end of the coaxial cable can also be variable. There are many instances for which this is true, including: a device whose input impedance changes with temperature (e.g., a resonant antenna in a medium of changing permittivity, as in microwave ablation), whose impedance changes over time, changed based on loading further downstream in the network, etc. In these instances, it may be beneficial to change the impedance of the coaxial line feeding these devices. For example, a microwave ablation antenna at the end of a coaxial cable may resonate inside the tissue at an initial temperature, T0. As the tissue warms, the input impedance and, thus, the resonant frequency of the antenna shift along with the dielectric properties of the tissue. This shift causes an impedance mismatch between the feeding coaxial cable and the antenna, which results in reflections from the antenna. This, in turn, results in reduced efficiency in the antenna, less of the desired tissue heating effect and more of the undesirable heating of the feed cable and peripheral tissue proximal to the antenna.


However, if the characteristic impedance of the cable is adjusted to continuously match the antenna, then lower reflections and less of the undesirable feed cable heating would occur. The present invention provides means for providing this matching by altering the fluid passed through the channels to adjust the characteristic impedance. The present invention also provides means for reducing the undesired heating by flowing coolant though the channels.


Experiments conducted in the development of embodiments for the present invention simulated and experimentally generated results to demonstrate this effect. In the simulations, a 0.1 mm layer of fluid was assumed to flow between the outer surface of the dielectric layer and the inner surface of the outer conductor. When the relative permittivity of this medium changes from 1-100, the characteristic impedance changes slightly (FIG. 4). FIG. 4 shows a graph of characteristic impedance of a simulated line versus relative permittivity of the fluid layer. The rest of the dielectric core was assumed to be PTFE (eps_r=1.8). Similarly, when the conductivity of the fluid layer is altered, larger changes in impedance can be observed (FIG. 5). FIG. 5 shows a graph of characteristic impedance versus conductivity of the fluid layer. Relative permittivity was assumed to be 1.8 in the fluid layer. A thicker fluid layer would result in more drastic changes in characteristic impedance. Experimental results show that not only is such a cable feasible, but the cable does not degrade (and may have improved) the reflection coefficient of the antenna. FIG. 6A-B shows the reflection coefficient versus frequency for a triaxial antenna with standard coaxial cable (top) and the same antenna fed by a water-filled cable (bottom).


The systems and devices of the present invention may be combined within various system/kit embodiments. For example, the present invention provides kits comprising one or more of a generator, a power distribution system, and an applicator device, along with any one or more accessory agents (e.g., surgical instruments, software for assisting in procedure, processors, temperature monitoring devices, etc.). The present invention is not limited to any particular accessory agent. Additionally, the present invention contemplates kits comprising instructions (e.g., ablation instructions, pharmaceutical instructions) along with the systems and devices of the present invention and/or a pharmaceutical agent (e.g., a sedating medication, a topical antiseptic, a topical anesthesia).


The devices of the present invention may be used in any medical procedure (e.g., percutaneous or surgical) involving delivery of energy (e.g., microwave energy) to a tissue region. The present invention is not limited to a particular type or kind of tissue region (e.g., brain, liver, heart, blood vessels, foot, lung, bone, etc.). For example, the systems of the present invention find use in ablating tumor regions. In such uses, the applicator device is inserted into, for example, a subject such that the distal end of the distal coaxial outer shield is positioned in the vicinity of the desired tissue region. Next, the generator is used to provide a desired amount of microwave energy to the power distribution system at a characteristic impedance level, which in turn provides the energy at a characteristic impedance level to the applicator device. Next, in some embodiments, through use of a visualizing agent, the distal coaxial center conductor is extended from the distal coaxial outer shield in a manner retaining the characteristic impedance level. Next, a desired amount of microwave energy is delivered to the desired tissue region (e.g., tumor) generating an electric field of sufficient strength to ablate the desired tissue region. Due to the characteristic impedance level maintained throughout the transmission lines of the applicator device, the overall temperature of the transmission lines is greatly reduced, resulting in a reduced chance for undesired tissue overheating. The present invention further provides methods involving the simultaneous use of multiple (e.g., two or more) applicator devices for the treatment of a tissue. The present invention further provides methods involving the simultaneous use of multiple (e.g., two or more) applicator devices for the treatment of a tissue. In some embodiments, the present invention provides methods wherein the simultaneous use of multiple antennas are phased to achieve constructive and destructive interference (e.g., for purposes of selectively destroying and sparing portions of a tissue region).


In some embodiments, the present invention further provides software for regulating the amount of microwave energy provided to a tissue region through monitoring of the temperature of the tissue region (e.g., through a feedback system). In such embodiments, the software is configured to interact with the systems for microwave therapy of the present invention such that it is able to raise or lower (e.g., tune) the amount of energy delivered to a tissue region. In some embodiments, the type of tissue being treated (e.g., liver) is inputted into the software for purposes of allowing the software to regulate (e.g., tune) the delivery of microwave energy to the tissue region based upon pre-calibrated methods for that particular type of tissue region. In other embodiments, the software provides a chart or diagram based upon a particular type of tissue region displaying characteristics useful to a user of the system. In some embodiments, the software provides energy delivering algorithms for purposes of, for example, slowly ramping power to avoid tissue cracking due to rapid out-gassing created by high temperatures. In some embodiments, the software allows a user to choose power, duration of treatment, different treatment algorithms for different tissue types, simultaneous application of power to the antennas in multiple antenna mode, switched power delivery between antennas, coherent and incoherent phasing, etc.


In some embodiments, the software is configured for imaging equipment (e.g., CT, MRI, ultrasound). In some embodiments, the imaging equipment software allows a user to make predictions based upon known thermodynamic and electrical properties of tissue and location of the antenna(s). In some embodiments, the imaging software allows the generation of a three-dimensional map of the location of a tissue region (e.g., tumor, arrhythmia), location of the antenna(s), and to generate a predicted map of the ablation zone.


All publications and patents mentioned in the above specification are herein incorporated by reference. Various modifications and variations of the described method and system of the invention will be apparent to those skilled in the art without departing from the scope and spirit of the invention. Although the invention has been described in connection with specific preferred embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. Indeed, various modifications of the described modes for carrying out the invention that are obvious to those skilled in the relevant fields are intended to be within the scope of the following claims.

Claims
  • 1. A system comprising: one or more devices configured for delivery of energy to a tissue; andone or more of a power generator, a temperature monitoring device, a power distributor, a coolant source, and a processor;wherein said one or more devices configured for delivery of energy to the tissue isa device comprising a feedline portion comprising an inner and outer conductor separated by dielectric material, and an antenna portion distal to said feedline portion,wherein said feedline portion has an outer diameter that is equal to or less than a 16-gauge needle and wherein said feedline portion comprises one or more coolant pathways between said inner conductor and said outer conductor,wherein the feedline portion has a proximal end and a distal end,wherein the antenna portion has a proximal end and a distal end,wherein said one or more coolant pathways are created by removing a portion of said dielectric material, wherein said one or more coolant pathways are non-linear along the feedline portion, wherein the one or more coolant pathways are non-linear with respect to a feedline portion axis from the proximal end of the feedline portion to the distal end of the feedline portion,wherein the inner conductor extends from the proximal end of the feedline portion to the distal end of the antenna portion,wherein the outer conductor and dielectric material extend from the proximal end of the feedline portion to the distal end of the feedline portion,wherein said outer diameter is equal to or less than a 20-gauge needle,wherein said one or more coolant pathways terminate within said feedline portion;wherein said feedline portion comprises a triaxial configuration having said inner conductor, said outer conductor, and a middle conductor disposed between the inner and outer conductors.
  • 2. The system of claim 1, wherein said energy is microwave energy.
  • 3. The system of claim 1, wherein said one or more coolant pathways comprise one or more tubes inserted within said feedline portion, wherein said one or more tubes are deformable tubes.
  • 4. The system of claim 1, wherein said middle conductor comprises a metal foil or plating; and/orwherein said middle conductor is less than 1 mm thick.
  • 5. The system of claim 1, wherein said antenna portion is not configured for contact with coolant from the one or more coolant pathways.
  • 6. The system of claim 1, further comprising a tip at said distal end of said antenna portion.
  • 7. The system of claim 1, wherein said one or more coolant pathways is configured such that, when coolant is present in said one or more coolant pathways, the coolant alters a characteristic impedance of the device as compared to the device in an absence of the coolant.
  • 8. The system of claim 1, wherein said one or more coolant pathways comprises two or more coolant pathways; wherein said device is configured to transfer a coolant in a first direction through a first of said two or more coolant pathways and in a second direction through a second of said two or more coolant pathways.
  • 9. The system of claim 1, wherein said one or more coolant pathway channels is configured to achieve cooling with gas coolants via a Joule-Thompson effect.
  • 10. The system of claim 1, wherein said one or more coolant pathways is configured to distribute liquid or gas, wherein said liquid or said gas is provided at its respective critical point temperature.
  • 11. The system of claim 1, wherein said dielectric material is solid, wherein portions of said inner conductor are connected with portions of said outer conductor via said solid dielectric material, wherein said one or more coolant pathways include regions where portions of said inner conductor and portions of said outer conductor are not connected via said solid dielectric material.
  • 12. A method of treating a tissue region, comprising: a) providing the system of claim 1;b) positioning the device in a vicinity of a tissue region, andc) delivering an amount of energy with said device to said tissue region.
  • 13. The method of claim 12, wherein said tissue region is a tumor.
  • 14. The method of claim 12, further comprising the step of passing a fluid through said one or more coolant pathways.
  • 15. The method of claim 14, wherein said passing occurs prior to said delivering.
  • 16. The method of claim 14, wherein said passing is conducted under conditions such that a characteristic impedance of said device is altered.
Parent Case Info

The present application is a continuation of U.S. patent application Ser. No. 11/728,460, filed Mar. 26, 2007, allowed as U.S. Pat. No. 10,363,092, which claims priority to U.S. Provisional Application Ser. No. 60/785,467, filed Mar. 24, 2006, the entire contents of which are herein incorporated by reference in their entries.

US Referenced Citations (437)
Number Name Date Kind
3800552 Sollami Apr 1974 A
3838242 Goucher Sep 1974 A
3991770 LeVeen Nov 1976 A
4057064 Morrison Nov 1977 A
4074718 Morrison Feb 1978 A
4312364 Convert Jan 1982 A
4375220 Matvias Mar 1983 A
4446874 Vaguine May 1984 A
4494539 Zenitani Jan 1985 A
4534347 Taylor Aug 1985 A
4557272 Carr Dec 1985 A
4586491 Carpenter May 1986 A
4589424 Vaguine May 1986 A
4601296 Yerushalmi Jul 1986 A
4621642 Chen Nov 1986 A
4627435 Hoskin Dec 1986 A
4641649 Walinsky Feb 1987 A
4643186 Rosen Feb 1987 A
4662383 Sogawa May 1987 A
4700716 Kasevich Oct 1987 A
4712559 Turner Dec 1987 A
4776086 Kasevich Oct 1988 A
4790311 Ruiz Dec 1988 A
4860752 Turner Aug 1989 A
4880015 Nierman Nov 1989 A
4901719 Trenconsky Feb 1990 A
4945912 Langberg Aug 1990 A
4974587 Turner Dec 1990 A
5007437 Sterzer Apr 1991 A
5026959 Ito Jun 1991 A
5057104 Chess Oct 1991 A
5057106 Kasevich Oct 1991 A
5074861 Schneider Dec 1991 A
RE33791 Carr Jan 1992 E
5098429 Sterzer Mar 1992 A
5129396 Rosen Jul 1992 A
5150717 Rosen et al. Sep 1992 A
5167619 Wuchinich Dec 1992 A
5211625 Sakurai May 1993 A
5213561 Weinstein May 1993 A
5246438 Langberg Sep 1993 A
5248312 Langberg Sep 1993 A
5275597 Higgins Jan 1994 A
5277201 Stern Jan 1994 A
5281213 Midler Jan 1994 A
5281217 Edwards Jan 1994 A
5295955 Rosen Mar 1994 A
5300099 Rudie Apr 1994 A
5301687 Wong Apr 1994 A
5314466 Stern May 1994 A
5344418 Ghaffari Sep 1994 A
5344435 Turner Sep 1994 A
5348554 Imran Sep 1994 A
5358515 Hurter Oct 1994 A
5364392 Warner Nov 1994 A
5366490 Edwards Nov 1994 A
5369251 King Nov 1994 A
5370678 Edwards Dec 1994 A
5405346 Grundy Apr 1995 A
5431649 Muller Jul 1995 A
5433740 Yamaguchi Jul 1995 A
5456684 Schmidt Oct 1995 A
5462556 Powers Oct 1995 A
5472423 Gronauer Dec 1995 A
5480417 Hascoet Jan 1996 A
5489256 Adair Feb 1996 A
5507743 Edwards Apr 1996 A
5531677 Lundquist Jul 1996 A
5540649 Bonnell et al. Jul 1996 A
5559295 Sheryll Sep 1996 A
5575794 Walus Nov 1996 A
5578029 Trelles Nov 1996 A
5591227 Dinh Jan 1997 A
5597146 Putman Jan 1997 A
5599295 Rosen Feb 1997 A
5599352 Dinh Feb 1997 A
5603697 Diederich Feb 1997 A
5620479 Diederich Apr 1997 A
5643175 Adair Jul 1997 A
5647871 Levine Jul 1997 A
5688267 Panescu et al. Nov 1997 A
5693082 Warner Dec 1997 A
5697949 Giurtino Dec 1997 A
5716389 Walinsky Feb 1998 A
5737384 Fenn Apr 1998 A
5741249 Moss Apr 1998 A
5755752 Segal May 1998 A
5755754 Rudie May 1998 A
5759200 Azar Jun 1998 A
5776129 Mersch Jul 1998 A
5776176 Rudie Jul 1998 A
5782827 Gough Jul 1998 A
5788692 Campbell Aug 1998 A
5788694 Vancaillie Aug 1998 A
5800494 Campbell Sep 1998 A
5810803 Moss Sep 1998 A
5810804 Gough Sep 1998 A
5849029 Eckhouse Dec 1998 A
5902251 Vanhooydonk May 1999 A
5904709 Arndt May 1999 A
5921935 Hickey Jul 1999 A
5957969 Warner Sep 1999 A
5963082 Dick Oct 1999 A
5995875 Biewett Nov 1999 A
6002968 Edwards Dec 1999 A
6012457 Lesh Jan 2000 A
6016811 Knopp Jan 2000 A
6026331 Feldberg Feb 2000 A
6044846 Edwards Apr 2000 A
6056744 Edwards May 2000 A
6067475 Graves May 2000 A
6073052 Zelickson Jun 2000 A
6083255 Laufer Jul 2000 A
6086529 Arndt Jul 2000 A
6091995 Ingle et al. Jul 2000 A
6097985 Zasevich Aug 2000 A
6102885 Bass Aug 2000 A
6104959 Spertell Aug 2000 A
6106524 Eggers Aug 2000 A
6120496 Whayne et al. Sep 2000 A
6165163 Chien et al. Dec 2000 A
6174307 Daniel et al. Jan 2001 B1
6182666 Dobak, III Feb 2001 B1
6188930 Carson Feb 2001 B1
6190382 Ormsby Feb 2001 B1
6208903 Richards Mar 2001 B1
6210323 Gilhuly et al. Apr 2001 B1
6223085 Dann Apr 2001 B1
6312427 Berube Apr 2001 B1
6230060 Mawhinney May 2001 B1
6235022 Hallock et al. May 2001 B1
6241725 Cosman Jun 2001 B1
6245062 Berube Jun 2001 B1
6246784 Summers Jun 2001 B1
6246905 Mogul Jun 2001 B1
6251128 Knopp Jun 2001 B1
6254598 Edwards Jul 2001 B1
6273884 Altshuler Aug 2001 B1
6273885 Koop Aug 2001 B1
6273886 Edwards et al. Aug 2001 B1
6277113 Berube Aug 2001 B1
6287302 Berube Sep 2001 B1
6306130 Anderson Oct 2001 B1
6306132 Moorman Oct 2001 B1
6325796 Berube Dec 2001 B1
6347251 Deng Feb 2002 B1
6355033 Moorman Mar 2002 B1
6364876 Erb Apr 2002 B1
6383182 Berube May 2002 B1
6395803 Angeletakis May 2002 B1
6398781 Goble Jun 2002 B1
6402742 Blewett Jun 2002 B1
6427089 Knowlton Jul 2002 B1
6435872 Nagel Aug 2002 B1
6461351 Woodruff et al. Oct 2002 B1
6461352 Morgan Oct 2002 B2
6471696 Berube Oct 2002 B1
6500174 Maguire Dec 2002 B1
6506189 Rittman Jan 2003 B1
6514249 Maguire Feb 2003 B1
6524308 Muller Feb 2003 B1
6527768 Berube Mar 2003 B2
6530922 Cosman Mar 2003 B2
6546077 Chornenky Apr 2003 B2
6575969 Rittman, III Jun 2003 B1
6577903 Cronin Jun 2003 B1
6582426 Moorman et al. Jun 2003 B2
6582486 Delpiano Jun 2003 B1
6585733 Wellman Jul 2003 B2
6593395 Angeletakis Jul 2003 B2
6602074 Suh Aug 2003 B1
6622731 Daniel Sep 2003 B2
6635055 Cronin Oct 2003 B1
6638277 Schaefer et al. Oct 2003 B2
6652520 Moorman Nov 2003 B2
6663625 Ormsby Dec 2003 B1
6666579 Jensen Dec 2003 B2
6683625 Muthusamy et al. Jan 2004 B2
6694163 Vining Feb 2004 B1
6699240 Francischelli Mar 2004 B2
6709271 Yin Mar 2004 B2
6740107 Loeb May 2004 B2
6749606 Keast Jun 2004 B2
6752767 Turovskiy Jun 2004 B2
D493531 Padain Jul 2004 S
6770070 Balbierz Aug 2004 B1
6780178 Palanker Aug 2004 B2
6673068 Berube Oct 2004 B1
6802840 Chin Oct 2004 B2
6817976 Rovegno Nov 2004 B2
6817999 Berube Nov 2004 B2
6823218 Berube Nov 2004 B2
6837712 Qian Jan 2005 B2
6847848 Sterzer Jan 2005 B2
6849075 Bertolero et al. Feb 2005 B2
6852091 Edwards Feb 2005 B2
6866624 Chornenky Mar 2005 B2
6866663 Edwards Mar 2005 B2
6869431 Maguire Mar 2005 B2
6878147 Prakash Apr 2005 B2
6890968 Angeletakis May 2005 B2
6893436 Woodard May 2005 B2
6898454 Atalar May 2005 B2
D507649 Padain Jul 2005 S
6918905 Neuberger Jul 2005 B2
6924325 Qian Aug 2005 B2
6957108 Turner Oct 2005 B2
6962586 Berube Nov 2005 B2
6972016 Hill Dec 2005 B2
6976986 Berube Dec 2005 B2
6994546 Fischer Feb 2006 B2
7022105 Edwards Apr 2006 B1
7033352 Gauthier Apr 2006 B1
7097641 Arless Aug 2006 B1
7101369 van der Weide Sep 2006 B2
7115126 Berube et al. Oct 2006 B2
7128739 Prakash Oct 2006 B2
7142633 Eberhard Nov 2006 B2
7147632 Prakash Dec 2006 B2
7153298 Cohen Dec 2006 B1
7156842 Sartor et al. Jan 2007 B2
7160289 Cohen Jan 2007 B2
7160292 Moorman Jan 2007 B2
7182762 Bortkiewicz Feb 2007 B2
7184824 Hashimshony Feb 2007 B2
7197363 Prakash Mar 2007 B2
7233820 Gilboa Jun 2007 B2
7244254 Brace Jul 2007 B2
7263997 Madsen et al. Sep 2007 B2
7266407 Li Sep 2007 B2
7282049 Orszulak Oct 2007 B2
7311703 Turovskiy Dec 2007 B2
7318824 Prakash Jan 2008 B2
7324104 Bitter Jan 2008 B1
7331960 Schaer Feb 2008 B2
7381208 van der Walt Jun 2008 B2
7400929 Zelickson et al. Jul 2008 B2
7402140 Spero Jul 2008 B2
7410484 Littrup Aug 2008 B2
7467015 van der Weide Dec 2008 B2
7473219 Glenn Jan 2009 B1
7527623 Prakash May 2009 B2
7594313 Prakash Sep 2009 B2
7601149 DiCarlo et al. Oct 2009 B2
7625369 Abboud Dec 2009 B2
7722620 Truckai May 2010 B2
7731677 Sakurai Jun 2010 B2
7815637 Ormsby Oct 2010 B2
7826904 Appling Nov 2010 B2
7862559 Prakash Jan 2011 B2
7875024 Turovskiy Jan 2011 B2
8035570 Prakash Oct 2011 B2
8059059 Bonn Nov 2011 B2
8093500 Deborski Jan 2012 B2
8109895 Williams et al. Feb 2012 B2
8147511 Perry Apr 2012 B2
8152799 Ormsby Apr 2012 B2
8155418 Delso Apr 2012 B2
8235981 Prakash Aug 2012 B2
8357148 Boulais Jan 2013 B2
8403924 Behnke Mar 2013 B2
8430871 Brannan Apr 2013 B2
8515554 Carr Aug 2013 B2
8523854 Willyard Sep 2013 B2
8540710 Johnson Sep 2013 B2
8574227 Hancock Nov 2013 B2
8643561 Prakash Feb 2014 B2
8653828 Hancock Feb 2014 B2
8655454 Prakash Feb 2014 B2
8672932 van der Weide Mar 2014 B2
8747398 Behnke Jun 2014 B2
8764744 Brannan Jul 2014 B2
8932281 Brannan Jan 2015 B2
8934989 Ormsby Jan 2015 B2
8945111 Brannan et al. Feb 2015 B2
8968290 Brannan Mar 2015 B2
9008793 Cosman Apr 2015 B1
9011421 Brannan Apr 2015 B2
9017319 Brannan Apr 2015 B2
9041616 Prakash May 2015 B2
9072532 van der Weide Jul 2015 B2
9113926 Brannan Aug 2015 B2
9119649 van der Weide Sep 2015 B2
9119650 Brannan Sep 2015 B2
9161811 Cronin Oct 2015 B2
9173706 Rossetto Nov 2015 B2
9192436 Willyard Nov 2015 B2
9192438 Thiel Nov 2015 B2
9198725 Willyard Dec 2015 B2
9220441 Yoo Dec 2015 B2
20010020166 Daly et al. Sep 2001 A1
20010039416 Moorman et al. Nov 2001 A1
20010049524 Morgan Dec 2001 A1
20020022836 Goble Feb 2002 A1
20020026187 Swanson et al. Feb 2002 A1
20020040185 Atalar Apr 2002 A1
20020072742 Schaefer Jun 2002 A1
20020087151 Mody et al. Jul 2002 A1
20020087157 Sliwa et al. Jul 2002 A1
20020173780 Altshuler Nov 2002 A1
20020183740 Edwards Dec 2002 A1
20030032951 Rittman et al. Feb 2003 A1
20030060813 Loeb Mar 2003 A1
20030065317 Rudie Apr 2003 A1
20030088242 Prakash May 2003 A1
20030120268 Bertolero Jun 2003 A1
20040030367 Yamaki et al. Feb 2004 A1
20040068208 Cimino et al. Apr 2004 A1
20040082859 Schaer Apr 2004 A1
20040158237 Abboud Aug 2004 A1
20040186517 Hill et al. Sep 2004 A1
20040199154 Nahon Oct 2004 A1
20040215131 Sakurai Oct 2004 A1
20040215294 Littrup Oct 2004 A1
20040243004 Carr Dec 2004 A1
20040243200 Turner Dec 2004 A1
20040267248 Duong Dec 2004 A1
20050011885 Seghatol Jan 2005 A1
20050015081 Turovskiy Jan 2005 A1
20050075629 Chapelon Apr 2005 A1
20050107870 Wang May 2005 A1
20050109900 Schilt et al. May 2005 A1
20050113824 Sartor May 2005 A1
20050143726 Bortkiewicz Jun 2005 A1
20050149010 Turovskiy Jul 2005 A1
20050165389 Swain Jul 2005 A1
20050177209 Leung et al. Aug 2005 A1
20050245919 van der Weide Nov 2005 A1
20050245920 Vitullo et al. Nov 2005 A1
20060064083 Khalaj et al. Mar 2006 A1
20060079886 Orszulak et al. Apr 2006 A1
20060094956 Vismanathan May 2006 A1
20060106281 Boulais May 2006 A1
20060122625 Truckai Jun 2006 A1
20060129140 Todd et al. Jun 2006 A1
20060155270 Hancock Jul 2006 A1
20060171506 Lovoi Aug 2006 A1
20060189973 van der Weide Aug 2006 A1
20060200026 Wallace et al. Sep 2006 A1
20060200120 DiCarlo Sep 2006 A1
20060224220 Zelickson Oct 2006 A1
20060264921 Deutsch et al. Nov 2006 A1
20060289528 Chiu Dec 2006 A1
20070016180 Lee, Jr. et al. Jan 2007 A1
20070021741 Abboud et al. Jan 2007 A1
20070066972 Ormsby Mar 2007 A1
20070203551 Cronin Aug 2007 A1
20070208389 Amundson et al. Sep 2007 A1
20070230757 Trachtenberg et al. Oct 2007 A1
20070270924 McCann et al. Nov 2007 A1
20070276362 Rioux Nov 2007 A1
20070282319 van der Weide Dec 2007 A1
20070288079 van der Weide Dec 2007 A1
20080033424 Van Der Weide Feb 2008 A1
20080045938 Van Der Weide et al. Feb 2008 A1
20080114345 Arless et al. May 2008 A1
20080147056 Van der Weide Jun 2008 A1
20080161890 Lafontaine Jul 2008 A1
20080188868 Weitzner et al. Aug 2008 A1
20080188869 Weitzner et al. Aug 2008 A1
20080188871 Smith et al. Aug 2008 A1
20080188890 Weitzner et al. Aug 2008 A1
20080195226 Williams et al. Aug 2008 A1
20080221391 Weitzner et al. Sep 2008 A1
20080243176 Weitzner et al. Oct 2008 A1
20090005766 Brannan Jan 2009 A1
20090054962 Lefler Feb 2009 A1
20090076492 Behnke Mar 2009 A1
20090118725 Auth et al. May 2009 A1
20090187180 Brannan Jul 2009 A1
20090187186 Jakus Jul 2009 A1
20090196480 Nields et al. Aug 2009 A1
20090222002 Bonn et al. Sep 2009 A1
20090281536 Beckman et al. Nov 2009 A1
20090306644 Mayse et al. Dec 2009 A1
20100023866 Peck et al. Jan 2010 A1
20100045558 Rossetto Feb 2010 A1
20100045559 Rossetto Feb 2010 A1
20100076424 Carr Mar 2010 A1
20100081928 Hyde et al. Apr 2010 A1
20100137796 Perry et al. Jun 2010 A1
20100228244 Hancock Sep 2010 A1
20100268223 Coe Oct 2010 A1
20100286791 Goldsmith Nov 2010 A1
20100292766 Duong Nov 2010 A1
20100305561 Prakash et al. Dec 2010 A1
20100312095 Jenkins Dec 2010 A1
20100312096 Guttman Dec 2010 A1
20100317962 Jenkins Dec 2010 A1
20110077635 Bonn Mar 2011 A1
20110118723 Turner et al. May 2011 A1
20110118725 Mayse May 2011 A1
20110213352 Lee et al. Sep 2011 A1
20110238060 Lee, Jr. Sep 2011 A1
20110238061 van der Weide Sep 2011 A1
20110257647 Mayse Oct 2011 A1
20110301587 Deem Dec 2011 A1
20120016358 Mayse Jan 2012 A1
20120053577 Lee et al. Mar 2012 A1
20120116286 Williams et al. May 2012 A1
20120182134 Doyle Jul 2012 A1
20120194409 Brannan Aug 2012 A1
20120203216 Mayse et al. Aug 2012 A1
20120203222 Mayse Aug 2012 A1
20120209257 van der Weide Aug 2012 A1
20120209261 Mayse Aug 2012 A1
20120209296 Martin Aug 2012 A1
20120232544 Willyard Sep 2012 A1
20120232549 Willyard Sep 2012 A1
20120310228 Bonn et al. Dec 2012 A1
20120316551 can der Weide Dec 2012 A1
20120316552 Mayse Dec 2012 A1
20120316559 Mayse Dec 2012 A1
20130004037 Scheuering Jan 2013 A1
20130023866 Stringham Jan 2013 A1
20130072924 Burgener Mar 2013 A1
20130116679 van der Weide et al. May 2013 A1
20130123598 Jenkins May 2013 A1
20130131496 Jenkins May 2013 A1
20130165915 Thiel Jun 2013 A1
20130259335 Mallya et al. Oct 2013 A1
20130306543 Beisser Nov 2013 A1
20130338530 Kassab Dec 2013 A1
20140005706 Gelfand et al. Jan 2014 A1
20140046174 Ladtkow et al. Feb 2014 A1
20140046176 Ladtkow Feb 2014 A1
20140152656 Yoo Jun 2014 A1
20140163664 Goldsmith et al. Jun 2014 A1
20140276033 Brannan Sep 2014 A1
20140276200 Brannan Sep 2014 A1
20150148792 Kim May 2015 A1
20150150628 Buysse Jun 2015 A1
20150164587 Bonn et al. Jun 2015 A1
20150190193 Mayse Jul 2015 A1
20150250540 Behdad et al. Sep 2015 A1
20150351839 Brannan Dec 2015 A1
20150374438 van der Weide Dec 2015 A1
Foreign Referenced Citations (77)
Number Date Country
2015202149 May 2015 AU
1593353 Mar 2005 CN
1703168 Nov 2005 CN
2753408 Jan 2006 CN
201267529 Jul 2009 CN
101511295 Aug 2009 CN
101563042 Oct 2009 CN
1186274 Mar 2002 EP
1265532 Dec 2002 EP
2388039 Nov 2003 EP
1395190 Mar 2004 EP
1450710 Sep 2004 EP
1499251 Jan 2005 EP
2406521 Apr 2005 EP
1542607 Jun 2005 EP
1723922 Nov 2006 EP
2098184 Sep 2009 EP
2295000 Mar 2011 EP
2316370 May 2011 EP
1659969 Oct 2012 EP
10-192286 Jul 1998 JP
2002-541884 Dec 2002 JP
2003-530139 Oct 2003 JP
2003-534037 Nov 2003 JP
2004-188179 Jul 2004 JP
2005-522274 Jul 2005 JP
2007-029457 Feb 2007 JP
2007-532024 Nov 2007 JP
2008-142467 Jun 2008 JP
2009-006150 Jan 2009 JP
2009-521264 Jun 2009 JP
2009-521967 Jun 2009 JP
2009-207898 Sep 2009 JP
2009-285463 Dec 2009 JP
2010-505573 Feb 2010 JP
2010-050975 Mar 2010 JP
2011-511538 Apr 2011 JP
2011-092720 May 2011 JP
2011-152414 Aug 2011 JP
WO 1992004934 Apr 1992 WO
WO 1993009845 May 1993 WO
WO 1995004385 Sep 1995 WO
WO 1997048449 Dec 1997 WO
WO 1999056643 Nov 1999 WO
WO 2000057811 Oct 2000 WO
WO 2001070114 Sep 2001 WO
WO 2003039385 May 2003 WO
WO 2003086190 Oct 2003 WO
WO 2003086498 Oct 2003 WO
WO 2003088806 Oct 2003 WO
WO 2003088858 Oct 2003 WO
WO 2004004586 Jan 2004 WO
WO 2004026122 Jan 2004 WO
WO 2004033039 Apr 2004 WO
WO 2004084748 Oct 2004 WO
WO 2004112628 Dec 2004 WO
WO 2005011049 Feb 2005 WO
WO 2005034783 Apr 2005 WO
WO 2005110265 Nov 2005 WO
WO 2006002843 Jan 2006 WO
WO 2006002943 Jan 2006 WO
WO 2006004585 Jan 2006 WO
WO 2006005579 Jan 2006 WO
WO 2006008481 Jan 2006 WO
WO 2006084676 Aug 2006 WO
WO 2006122149 Nov 2006 WO
WO 2006127847 Nov 2006 WO
WO 2007076924 Jul 2007 WO
WO 2007112103 Oct 2007 WO
WO 2008008545 Jan 2008 WO
WO 2008044013 Apr 2008 WO
WO 2008142686 Nov 2008 WO
WO 2010067360 Jun 2010 WO
WO 2011008903 Jan 2011 WO
WO 2011017168 Feb 2011 WO
WO 2011140087 Nov 2011 WO
WO 2013173481 Nov 2013 WO
Non-Patent Literature Citations (30)
Entry
Brace, C. et al ‘Microwave Ablation with Triaxial Antenna: Results in ex vivo Bovine Liver’ IEEE Transactions on Microwave Theory and Techniques, vol. 53, No. 1 Jan. 2005.
European Search Report dated Mar. 9, 2015, EP Patent Application No. 14189493.1.
Extended European Search Report re: 11778168 dated Sep. 24, 2013.
Golio, ‘The RF and microwave handbook’ Edition 2 Published by CRC Press 2001 ISBN 0849338592X, 97808493859626.
Guy, AW (1971) IEEE Trans. Microwave Theory Tech. 19 pp. 205-214.
Head, Hayden W., et al., “Thermal Ablation for Hepatocellular Carcinoma,” Gastroenterology, 2004:127:S167-S178.
International Preliminary Report on Patentability re: PCT/US2010/043558 dated Jan. 31, 2012.
International Preliminary Report on Patentability re: PCT/US2011/035000 dated Nov. 6, 2012.
International Preliminary Report on Patentability re: PCT/US2012/071310 dated Aug. 19, 2014.
International Search Report & Written Opinion, International Patent Application No. PCT/US2017/027424, dated Oct. 9, 2017.
International Search Report on Patentability re: PCT/US2007/016082 dated Jul. 21, 2008.
International Search Report PCT US/2006/028821 dated Mar. 21, 2007.
International Search Report PCT/US2005/014534 dated Nov. 29, 2005.
International Search Report PCT/US2006/017981 dated Sep. 7, 2006.
International Search Report PCT/US2006/033341 dated Aug. 17, 2007.
U.S. Appl. No. 11/440,331, filed May 24, 2006.
U.S. Appl. No. 11/452,637, filed Jun. 14, 2006.
U.S. Appl. No. 11/502,783, filed Aug. 11, 2006.
U.S. Appl. No. 11/514,628, filed Sep. 1, 2006.
U.S. Appl. No. 11/728,428, filed Mar. 26, 2007.
U.S. Appl. No. 11/728,457, filed Mar. 26, 2007.
U.S. Appl. No. 11/728,460, filed Mar. 26, 2007.
U.S. Appl. No. 60/679,722, filed May 10, 2005.
U.S. Appl. No. 60/785,466, filed Mar. 24, 2006.
U.S. Appl. No. 60/785,467, filed Mar. 24, 2006.
U.S. Appl. No. 60/785,690, filed Mar. 24, 2006.
U.S. Appl. No. 60/831,055, filed Jul. 14, 2006.
International Search Report, PCT/US06/032811, dated Jan. 25, 2007.
International Search Report, PCT/US06/031644, dated Aug. 17, 2007.
“Carbon dioxide.” Carbon dioxide—New World Encyclopedia. Web. <http://www.newworldencyclopedia.org/entry/Carbon_dioxide>.
Related Publications (1)
Number Date Country
20190350652 A1 Nov 2019 US
Provisional Applications (1)
Number Date Country
60785467 Mar 2006 US
Continuations (1)
Number Date Country
Parent 11728460 Mar 2007 US
Child 16525067 US